Plus LibraryBy pinki@katapult.biz / February 13, 2025 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Clear Displaying 1,876 - 1,900 of 2,875 « 1 … 74 75 76 77 78 … 115 » Neo-Adjuvant and Adjuvant Immunotherapy for Non-Small Cell Lung Cancer Luis Raez, MD View PDF Advances in chemotherapy in Lung cancer Luis Raez, MD View PDF Metastatic NSCLC Immunotherapy Updates Luis Raez, MD, FACP View PDF Metastatic NSCLC Immunotherapy Updates Luis Raez, MD, FACP View Video Neo-Adjuvant and Adjuvant Immuntherapy for Non-Small Cell Lung Cancer Luis Raez, MD, FACP, FCCP View PDF Metastatic Lung Immunotherapy Updates Luis Raez, MD, FACP, FCCP View PDF Immunotherapy in Advanced/ Metastatic NSCLC Luis Raez, MD, FACP, FCCP View PDF Immunotherapy in Advanced/ Metastatic NSCLC Luis Raez, MD, FACP, FCCP View Video Metastatic Lung Immunotherapy Updates Luis Raez, MD, FACP, FCCP View Video What is the Best Way to Assess Response to Therapy? Is Complete Pathologic Response the Best Surrogate? Lynette M. Sholl, MD View PDF ALK Mutant NSCLC Lyudmila Bazhenova, MD View PDF Updates in Bispecific Antibodies in NSCLC Lyudmila Bazhenova, MD View PDF Updates in Bispecific Antibodies in NSCLC Lyudmila Bazhenova, MD View Video Update Progress in Targeted Therapies for Early-Stage NSCLC Lyudmila Bazhenova, MD View PDF Uncommon Oncogenic Drivers in NSCLC Marianna Koczywas, MD View PDF SCLC Case Marie Suga, MD, MPH View PDF SCLC Case Marie Suga, MD, MPH View Video Neoadjuvant Immunotherapy Position Marina Garassino, MD View PDF Neoadjuvant Immunotherapy Position Marina Garassino, MD View Video Antibody Drug Conjugates in NSCLC Marina Garassino, MD View PDF How to Choose Front Line Therapy for Metastatic NSCLC Mark A. Socinski, MD View PDF What Is Next After Osimertinib Progression? Mark A. Socinski, MD View PDF What Is Next After Osimertinib Progression? Mark A. Socinski, MD View Video How to Improve Targeted Therapy in NSCLC? Where are the Major Gaps? Mark Kris, MD View PDF How to Improve Targeted Therapy in NSCLC? Where are the Major Gaps? Mark Kris, MD View Video
